Pure red cell aplasia associated with chronic lymphocytic leukemia

Pure red cell aplasia associated with chronic lymphocytic leukemia is a rare, acquired hematologic complication occurring in patients with the mature B-cell malignancy chronic lymphocytic leukemia It is clinically defined by profound normocytic normochromic anemia and severe reticulocytopenia alongside a near-total absence or marked reduction of erythroid precursors in the bone marrow, occurring in the presence of preserved megakaryocytic and myeloid lineages

Pure red cell aplasia associated with chronic lymphocytic leukemia is a rare, acquired hematologic complication occurring in patients with the mature B-cell malignancy chronic lymphocytic leukemia The condition affects the hematopoietic system and is primarily driven by immune-mediated suppression—frequently involving abnormal T-cell activity or autoantibodies targeting early erythroid progenitors—though it can also be triggered by opportunistic infections or antineoplastic therapy

The condition affects the hematopoietic system and is primarily driven by immune-mediated suppression—frequently involving abnormal T-cell activity or autoantibodies targeting early erythroid progenitors—though it can also be triggered by opportunistic infections or antineoplastic therapy

The condition affects the hematopoietic system and is primarily driven by immune-mediated suppression—frequently involving abnormal T-cell activity or autoantibodies targeting early erythroid progenitors—though it can also be triggered by opportunistic infections or antineoplastic therapy